Dabigatran vs. Oral Anti-Xa Inhibitors in S. Aureus Bacteremia
Abroad (travel likely)RecruitingPHASE4
Conditions
Staphylococcus Aureus Endocarditis · Staphylococcus Aureus Septicemia · Staphylococcus Aureus Bacteremia · Staphylococcus Aureus Bloodstream Infection · S. Aureus Bacteremia · S. Aureus Bloodstream Infection
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
McGill University Health Centre (Royal Victoria Hospital and Montreal General Hospital), Montreal, Quebec, Canada
Contact: Principal Investigator (Emily G McDonald, MD MSc)Contact: Principal Investigator (Todd C Lee, MD MPH FIDSA)Matthew P. Cheng, MD SM (Sub-investigator)Patrick Lawler, MD MPH (Sub-investigator)Alexander Lawandi, MD MSc (Sub-investigator)
Study leads
Emily G McDonald, MD MSC
Principal Investigator
Research Institute of the McGill University Health Centre